TP53 and cervical carcinoma: We also obtained a significant result that TP53 rs1042522 polymorphism increased the risk of cervical cancer in studies without definite adjustments in one model (CC + CG vs GG: OR = 1.836, 95% CI: 1.084-3.110, 95% PI: 0.284-11.875).